No Data
No Data
GSK Settles Zantac Litigation in Illinois, US
GSK (GSK.L) entered a confidential settlement with Martin Gross, who filed a case against the company's heartburn medication ranitidine, marketed as Zantac, in the Illinois state court in the US. The
Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
GSK Reaches Confidential Settlement in Illinois Zantac Litigation
GSK (GSK) Price: 38.92, Change: +0.27, Percent Change: +0.71
Express News | GSK Issues Statement Regarding The Zantac (Ranitidine) Litigation; Has Reached A Confidential Settlement With Martin Gross; GSK Does Not Admit Any Liability In This Settlement
GSK: Case Is Related to Ranitidine Litigation
GSK: Case Is Related to Ranitidine Litigation